Submit Comments by 08/01/2023 Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the FDA considers your comment […]

Product: Drugs Issuing Office: Center for Drug Evaluation and Research United States RE:                        Notice of Unlawful Sale of Unapproved and Misbranded Drugs Related to Coronavirus […]

Product: Drugs Date:               April 27, 2020 RE:                 Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19) This is to advise you that the […]

Product: Drugs Recipient: Recipient Name David Raes Vivify Holistic Clinic 272 Wellington StreetSarnia ON N7T 1H2Canada [email protected] Issuing Office: Center for Drug Evaluation and Research | […]

Product: Drugs Recipient: Recipient Name Mr. Michael Reiber Prefense LLC 2509 Pettibone AvenueMuscatine, IA 52761United States [email protected] Issuing Office: Center for Drug Evaluation and Research | […]

Delivery Method: Via Overnight Delivery Product: Animal & VeterinaryDrugsFood & Beverages Recipient: Recipient Name Mr. Michael Johnson Homero Corp DBA Natures CBD Oil Distribution 297 S. […]

Product: Drugs Date:               April 21, 2020 RE:                  Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19) This is to advise you that the […]

Product: Drugs Recipient: Recipient Name Mr. Puneet Nanda GuruNanda LLC 6645 Caballero Blvd.Buena Park, CA 90620United States [email protected] Issuing Office: Center for Drug Evaluation and Research […]

Product: Drugs Recipient: Recipient Name Jennifer Hickman Colloidal Vitality LLC/Vital Silver 3183 Forest Creek Dr.Melbourne, FL 32901United States [email protected] Issuing Office: Center for Drug Evaluation and […]